Skip to main content
. 2015 Aug 11;20(8):14487–14503. doi: 10.3390/molecules200814487

Figure 6.

Figure 6

Neuroprotective effect of intranasal administration of SkQR1. (A) Infarct volume was measured in the MR T2-weighted images obtained 24 h after MCAO; (B) Neurological status estimated using limb-placing test. Animals were tested 24 h after MCAO. * denotes significant difference from the MCAO + i/n Vehicle vs. MCAO group i/n treated SkQR1 (p < 0.05) (Student’s t-test for (A); the Mann-Whitney u-test for (B)).